Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3708539rdf:typepubmed:Citationlld:pubmed
pubmed-article:3708539lifeskim:mentionsumls-concept:C0024299lld:lifeskim
pubmed-article:3708539lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3708539lifeskim:mentionsumls-concept:C1336753lld:lifeskim
pubmed-article:3708539lifeskim:mentionsumls-concept:C0205462lld:lifeskim
pubmed-article:3708539lifeskim:mentionsumls-concept:C1514474lld:lifeskim
pubmed-article:3708539lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:3708539pubmed:issue1lld:pubmed
pubmed-article:3708539pubmed:dateCreated1986-7-17lld:pubmed
pubmed-article:3708539pubmed:abstractTextPrognostic factors in 79 patients with malignant lymphomas involving the thyroid gland were analyzed. These patients suffered from progressively enlarging goiter with over 6 months duration in 60% of patients. The age at operation ranged from 16 to 80 years (median, 58 years). Male to female ratio was 1:1.8. Serum tests for antithyroid antibodies were positive in 83% of the patients, who also showed histologic evidence of chronic lymphocytic thyroiditis. Histologically, 52 cases (66%) were germinal center cell tumors with follicular or follicular and diffuse pattern in 9 cases. By the Working Formulation, 5-year survival rate of immunoblastic type (IBL) (13%) was much poorer than those of intermediate (79%) and low grade cases (92%) (P less than 0.001). The cases of IBL usually had a goiter of short duration, and frequently presented as advanced disease.lld:pubmed
pubmed-article:3708539pubmed:languageenglld:pubmed
pubmed-article:3708539pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3708539pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3708539pubmed:statusMEDLINElld:pubmed
pubmed-article:3708539pubmed:monthJullld:pubmed
pubmed-article:3708539pubmed:issn0008-543Xlld:pubmed
pubmed-article:3708539pubmed:authorpubmed-author:InoueAAlld:pubmed
pubmed-article:3708539pubmed:authorpubmed-author:AozasaKKlld:pubmed
pubmed-article:3708539pubmed:authorpubmed-author:TajimaKKlld:pubmed
pubmed-article:3708539pubmed:authorpubmed-author:KumaKKlld:pubmed
pubmed-article:3708539pubmed:authorpubmed-author:MatsuzukaFFlld:pubmed
pubmed-article:3708539pubmed:authorpubmed-author:MiyauchiAAlld:pubmed
pubmed-article:3708539pubmed:issnTypePrintlld:pubmed
pubmed-article:3708539pubmed:day1lld:pubmed
pubmed-article:3708539pubmed:volume58lld:pubmed
pubmed-article:3708539pubmed:ownerNLMlld:pubmed
pubmed-article:3708539pubmed:authorsCompleteYlld:pubmed
pubmed-article:3708539pubmed:pagination100-4lld:pubmed
pubmed-article:3708539pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:meshHeadingpubmed-meshheading:3708539-...lld:pubmed
pubmed-article:3708539pubmed:year1986lld:pubmed
pubmed-article:3708539pubmed:articleTitleMalignant lymphomas of the thyroid gland. Analysis of 79 patients with emphasis on histologic prognostic factors.lld:pubmed
pubmed-article:3708539pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3708539pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3708539lld:pubmed